4.4 Article

CXCR1 Regulates Pulmonary Anti-Pseudomonas Host Defense

Journal

JOURNAL OF INNATE IMMUNITY
Volume 8, Issue 4, Pages 362-373

Publisher

KARGER
DOI: 10.1159/000444125

Keywords

CXCR1; Chemokine receptors; Pseudomonas; Neutrophils; Cystic fibrosis; Toll-like receptor 5; Reactive oxygen species

Categories

Funding

  1. German Research Foundation (DFG, Emmy Noether Programme) [HA 5274/3-1]
  2. Fritz-Thyssen-Foundation
  3. CRC685 at Tubingen
  4. Novartis Foundation
  5. Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA

Ask authors/readers for more resources

Pseudomonas aeruginosa is a key opportunistic pathogen causing disease in cystic fibrosis (CF) and other lung diseases such as chronic obstructive pulmonary disease (COPD). However, the pulmonary host defense mechanisms regulating anti-P. aeruginosa immunity remain incompletely understood. Here we demonstrate, by studying an airway P. aeruginosa infection model, in vivo bioluminescence imaging, neutrophil effector responses and human airway samples, that the chemokine receptor CXCR1 regulates pulmonary host defense against P. aeruginosa. Mechanistically, CXCR1 regulates anti-Pseudomonas neutrophil responses through modulation of reactive oxygen species and interference with Toll-like receptor 5 expression. These studies define CXCR1 as a novel, noncanonical chemokine receptor that regulates pulmonary anti-Pseudomonas host defense with broad implications for CF, COPD and other infectious lung diseases. (C) 2016 S. Karger AG, Basel

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available